Suppr超能文献

强效和选择性的鞘氨醇 1-磷酸 1(S1P1)激动剂:新型异恶唑基系列的发现和 SAR。

Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.

机构信息

Bristol-Myers Squibb Research and Development , P.O. Box 4000, Princeton, New Jersey 08543, United States.

出版信息

J Med Chem. 2016 Mar 24;59(6):2820-40. doi: 10.1021/acs.jmedchem.6b00089. Epub 2016 Mar 10.

Abstract

Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1-5) and evokes a variety of cellular responses through their stimulation. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation. Agonism of S1P1, in particular, has been shown to play a significant role in lymphocyte trafficking from the thymus and secondary lymphoid organs, resulting in immunosuppression. This article will detail the discovery and SAR of a potent and selective series of isoxazole based full agonists of S1P1. Isoxazole 6d demonstrated impressive efficacy when administered orally in a rat model of arthritis and in a mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.

摘要

鞘氨醇 1-磷酸(S1P)是鞘氨醇 1-磷酸受体(S1P1-5)的内源性配体,通过刺激它们引发多种细胞反应。S1P 与 S1P 受体的相互作用在包括血管发育和稳定、淋巴细胞迁移和增殖在内的许多过程中发挥着基本的生理作用。特别是 S1P1 的激动作用已被证明在淋巴细胞从胸腺和次级淋巴器官的迁移中发挥重要作用,导致免疫抑制。本文将详细介绍一系列基于异恶唑的强效和选择性 S1P1 完全激动剂的发现和 SAR。异恶唑 6d 在关节炎大鼠模型和多发性硬化症的实验性自身免疫性脑脊髓炎(EAE)小鼠模型中口服给药时表现出令人印象深刻的疗效。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验